Hassan I, Powell G, Sidhu M, Hart WM, Denning DW (2009) Excess mortality, length of stay and cost attributable to candidaemia. J Inf Secur 59(5):360–365. https://doi.org/10.1016/j.jinf.2009.08.020
Article
CAS
Google Scholar
Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, Bartzavali C, Lambropoulou A, Xaplanteri P, Anastassiou ED, Marangos M, Spiliopoulou I, Christofidou M (2019) Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009–2017) in a university Greek hospital. Infection 47(2):209–216. https://doi.org/10.1007/s15010-018-1217-2
Article
PubMed
Google Scholar
Raja NS (2020) Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non-albicans in two district general hospitals in the United Kingdom. Int J Clin Pract 75(1):e13655. https://doi.org/10.1111/ijcp.13655
Article
CAS
PubMed
Google Scholar
Goemaere B, Becker P, Wijngaerden EV et al (2018) Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals. Mycoses 61(2):127–133. https://doi.org/10.1111/myc.12714
Article
CAS
PubMed
Google Scholar
Mencarini J, Mantengoli E, Tofani L, Riccobono E, Fornaini R, Bartalesi F, Corti G, Farese A, Pecile P, Boni L, Rossolini GM, Bartoloni A (2018) Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period. Infection 46(4):469–476. https://doi.org/10.1007/s15010-018-1139-z
Article
PubMed
Google Scholar
Kollef M, Micek S, Hampton N, Doherty JA, Kumar A (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739–1746. https://doi.org/10.1093/cid/cis305
Article
CAS
PubMed
Google Scholar
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 62(4):e1–e50. https://doi.org/10.1093/cid/civ933
Article
Google Scholar
Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ, for the Mycoses Study Group (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54(8):1110–1122. https://doi.org/10.1093/cid/cis021
Article
CAS
PubMed
Google Scholar
Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347(25):2020–2029. https://doi.org/10.1056/NEJMoa021585
Article
CAS
PubMed
Google Scholar
Henderson DK, Edwards JE, Montgomerie JZ (1981) Hematogenous Candida Endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis 143(5):655–661. https://doi.org/10.1093/infdis/143.5.655
Article
CAS
PubMed
Google Scholar
Parke DW, Jones DB, Gentry LO (1982) Endogenous endophthalmitis among patients with Candidemia. Ophthalmology 89(7):789–796. https://doi.org/10.1016/S0161-6420(82)34722-3
Article
PubMed
Google Scholar
Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL (1989) Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 87(6):614–620. https://doi.org/10.1016/S0002-9343(89)80392-4
Article
CAS
PubMed
Google Scholar
Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr, Wagener MM, Yu VL (1994) Intraocular candidiasis in patients with Candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 101(7):1302–1309. https://doi.org/10.1016/S0161-6420(94)31175-4
Article
CAS
PubMed
Google Scholar
Shah CP, McKey J, Spirn MJ, Maguire J (2008) Ocular candidiasis: a review. Br J Ophthalmol 92(4):466–468. https://doi.org/10.1136/bjo.2007.133405
Article
CAS
PubMed
Google Scholar
Oude Lashof AML, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ (2011) Ocular manifestations of Candidemia. Clin Infect Dis 53(3):262–268. https://doi.org/10.1093/cid/cir355
Article
PubMed
Google Scholar
Nagao M, Saito T, Doi S, Hotta G, Yamamoto M, Matsumura Y, Matsushima A, Ito Y, Takakura S, Ichiyama S (2012) Clinical characteristics and risk factors of ocular candidiasis. Diagn Microbiol Infect Dis 73(2):149–152. https://doi.org/10.1016/j.diagmicrobio.2012.03.006
Article
PubMed
Google Scholar
Tanaka H, Ishida K, Yamada W, Nishida T, Mochizuki K, Kawakami H (2016) Study of ocular candidiasis during nine-year period. J Infect Chemother Off J Jpn Soc Chemother 22(3):149–156. https://doi.org/10.1016/j.jiac.2015.12.001
Article
Google Scholar
Kato H, Yoshimura Y, Suido Y, Ide K, Sugiyama Y, Matsuno K, Nakajima H (2018) Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection. Infection 46(5):635–640. https://doi.org/10.1007/s15010-018-1163-z
Article
PubMed
Google Scholar
Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, Nakajima K, Mikamo H, Yamagishi Y, Kasahara K, Yoshihara S, Ukimura A, Yoshida K, Yoshinaga N, Izumi M, Kakeya H, Yamada K, Kawamura H, Endou K, Yamanaka K, Yoshioka M, Amino K, Ikeuchi H, Uchino M, Miyazaki Y (2019) The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia. PLoS One 14(5):e0216956. https://doi.org/10.1371/journal.pone.0216956
Article
CAS
PubMed
PubMed Central
Google Scholar
Son H-J, Kim MJ, Lee S, Choi S, Jung KH, Jung J, Chong YP, Kim SH, Choi SH, Kim YS, Woo JH, Lee JY, Lee SO (2019) Risk factors and outcomes of patients with ocular involvement of candidemia. PLoS One 14(9):e0222356. https://doi.org/10.1371/journal.pone.0222356
Article
CAS
PubMed
PubMed Central
Google Scholar
O’Day DM, Head WS, Robinson RD et al (1985) Intraocular penetration of systemically administered antifungal agents. Curr Eye Res 4(2):131–134. https://doi.org/10.3109/02713688508999978
Article
PubMed
Google Scholar
Gauthier GM, Nork TM, Prince R, Andes D (2005) Subtherapeutic ocular penetration of Caspofungin and associated treatment failure in Candida albicans Endophthalmitis. Clin Infect Dis 41(3):e27–e28. https://doi.org/10.1086/431761
Article
CAS
PubMed
Google Scholar
Muñoz P, Vena A, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, Fortún J, Fernández-Ruiz M, Merino P, Losa JE, Loza A, Rivas RA, Bouza E, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI (2017) No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins. Diagn Microbiol Infect Dis 88(2):141–144. https://doi.org/10.1016/j.diagmicrobio.2017.02.014
Article
CAS
PubMed
Google Scholar
Gowda S, Desai PB, Hull VV et al (2009) A review on laboratory liver function tests. Pan Afr Med J 3:17
PubMed
PubMed Central
Google Scholar
Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, Flynn HW Jr (2012) Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 153(1):162–166.e1. https://doi.org/10.1016/j.ajo.2011.06.020
Article
PubMed
Google Scholar
Abe M, Kinjo Y, Ueno K, Takatsuka S, Nakamura S, Ogura S, Kimura M, Araoka H, Sadamoto S, Shinozaki M, Shibuya K, Yoneyama A, Kaku M, Miyazaki Y (2018) Differences in ocular complications between Candida albicans and non-albicans Candida infection analyzed by epidemiology and a mouse Ocular Candidiasis Model. Front Microbiol 9. https://doi.org/10.3389/fmicb.2018.02477
Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qiu H (2001) Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina Phila Pa 21(3):203–209. https://doi.org/10.1097/00006982-200106000-00001
Article
CAS
Google Scholar
Takebayashi H, Mizota A, Tanaka M (2006) Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 244(7):816–820. https://doi.org/10.1007/s00417-005-0182-5
Article
Google Scholar
Sobel JD (2007) Vulvovaginal candidosis. Lancet 369(9577):1961–1971. https://doi.org/10.1016/S0140-6736(07)60917-9
Article
PubMed
Google Scholar
Hassan A, Poon W, Baker M, Linton C, Mühlschlegel FA (2012) Confirmed Candida albicans endogenous fungal endophthalmitis in a patient with chronic candidiasis. Med Mycol Case Rep 1(1):42–44. https://doi.org/10.1016/j.mmcr.2012.06.001
Article
CAS
PubMed
PubMed Central
Google Scholar
Achkar JM, Fries BC (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23(2):253–273. https://doi.org/10.1128/CMR.00076-09
Article
PubMed
PubMed Central
Google Scholar
Suzuki R, Kuroda H, Matsubayashi H, Ishii A, Toyoda F, Kawarai Lefor A, Sugawara H (2015) Candidemia from an upper urinary tract infection complicated by candida endophthalmitis. Intern Med Tokyo Jpn 54(20):2693–2698. https://doi.org/10.2169/internalmedicine.54.4691
Article
CAS
Google Scholar
Denning DW (2003) Echinocandin antifungal drugs. Lancet 362(9390):1142–1151. https://doi.org/10.1016/S0140-6736(03)14472-8
Article
CAS
PubMed
Google Scholar
Suzuki T, Uno T, Chen G, Ohashi Y (2008) Ocular distribution of intravenously administered micafungin in rabbits. J Infect Chemother Off J Jpn Soc Chemother 14(3):204–207. https://doi.org/10.1007/s10156-008-0612-5
Article
CAS
Google Scholar
Mochizuki K, Sawada A, Suemori S, Kawakami H, Niwa Y, Kondo Y, Ohkusu K, Yamada N, Ogura S, Yaguchi T, Nishimura K, Kishino S (2013) Intraocular penetration of intravenous micafungin in inflamed human eyes. Antimicrob Agents Chemother 57(8):4027–4030. https://doi.org/10.1128/AAC.02300-12
Article
CAS
PubMed
PubMed Central
Google Scholar
Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC (2009) Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci 50(8):3783–3793. https://doi.org/10.1167/iovs.08-3051
Article
PubMed
PubMed Central
Google Scholar
Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, Hadley S, León C, Nucci M, Patterson TF, Perfect JR (2011) Early treatment of candidemia in adults: a review. Med Mycol 49(2):113–120. https://doi.org/10.3109/13693786.2010.512300
Article
PubMed
Google Scholar
Grim SA, Berger K, Teng C, Gupta S, Layden JE, Janda WM, Clark NM (2012) Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 67(3):707–714. https://doi.org/10.1093/jac/dkr511
Article
CAS
PubMed
Google Scholar
Nunes CZ, Marra AR, Edmond MB, da Silva VE, Pereira CAP (2013) Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicansbloodstream infection. BMC Infect Dis 13(1):486. https://doi.org/10.1186/1471-2334-13-486
Article
PubMed
PubMed Central
Google Scholar
Takesue Y, Ueda T, Mikamo H, Oda S, Takakura S, Kitagawa Y, Kohno S, on behalf of the ACTIONs Project, Masuda A, Yoshida C, Yasunaga C, Yamashita C, Nakataki E, Ohyagi H, Yagi H, Johnai H, Murai H, Hanamoto H, Nakamura I, Sanada I, Tandai I, Kuroki J, Ogawa J, Kawahara K, Amino K, Nakajima K, Yoshimoto K, Takeda K, Nakamura K, Suzuki K, Yamada K, Aizawa M, Hashimoto M, Ogata M, Shirano M, Kawada M, Kaneda M, Yoshioka M, Okuda N, Sugita N, Kikuchi N, Fuke S, Tsuchihashi S, Sugitani S, Ikuta S, Honda S, Nei T, Iwamura T, Yagi T, Kaji T, Ichimiya Y, Kobayashi Y, Minamishima Y, Goto Y, Hatano Y, Nagao Y, Yamagishi Y, Sashihara J, Tsukamoto A, Kawaoka T, Kobayashi M (2015) Management bundles for candidaemia: the impact of compliance on clinical outcomes. J Antimicrob Chemother 70(2):587–593. https://doi.org/10.1093/jac/dku414
Article
CAS
PubMed
Google Scholar